|
Tuesday, March 10 — 8:00 AM — CC Auditorium
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section A - GENITOURINARY PATHOLOGY
Chaired by: George Netto and Mark Rubin
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
Lymphatic Space Invasion Predicts Metastatic Behavior in Patients with Renal Cell Carcinoma, and It May Be an Independent Prognostic Factor for Overall Survival
(780)
LP Herrera, V Bird, I Reis, V Bird, M Jorda - University of Miami. Jackson Memorial Hospital and UM Sylvester Cancer Center, Miami, FL; University of Miami, Miami, FL; UM Sylvester. Division of Biostatistics, Miami, FL
|  Add |
| 8:15 |
Involvement of Renal Sinus Structures in Renal Cell Carcinoma, with an Emphasis on Renal Sinus Vein Invasion
(696)
A Adeniran, RH Thompson, A Gopalan, SW Fine, P Russo, VE Reuter, SK Tickoo - Memorial Sloan-Kettering Cancer Center, New York, NY
| Add |
| 8:30 |
Prognostic Factors of Clear Renal Cell Carcinoma in pT1a Cases
(901)
T Tsuzuki, N Nishikimi, A Katsuno, T Fujita, A Fukatsu, M Araki, N Sasa, Y Yoshino, R Hattori, M Goto - Nagoya Daini Red Cross Hospital, Nagoya, Japan; Okazaki Municipal Hospital, Okazaki, Japan; Chukyo Hospital, Nagoya, Japan; Komaki Municipal Hospital, Komaki, Japan; Toyohashi Municipal Hospital, Toyohashi, Japan; Nagoya University Hospital, Nagoya, Japan
| Add |
| 8:45 |
Fascin Regulates Prostate Cancer Cell Invasion and Is Associated with Metastasis and Biochemical Failure in Prostate Cancer
(742)
AD Darnel, E Behmoaram, RT Vollmer, J Corcos, K Bijian, K Sircar, J Su, J Jiao, MA Alaoui-Jamali, TA Bismar - McGill University and Lady Davis Cancer Institute, Montreal, QC, Canada; VA and Duke University Medical Centers, Durham, NC; University of Calgary, Calgary, AB, Canada
| Add |
| 9:00 |
PITX2 Promoter Methylation Status Is an Independent Prognostic Marker for Biochemical Recurrence in Patients with Prostate Cancer after Radical Prostatectomy
(727)
E Castanos-Velez, C Bangma, S Freedland, A Hartmann, M Ittmann, P Schatz, L Sun, A van Leenders, G Weiss, TM Wheeler - Epigenomics AG, Berlin, Germany; Erasmus MC, Rotterdam, Netherlands; Durham VA Medical Center, Durham, NC; University of Erlangen, Erlangen, Germany; Baylor College of Medicine, Houston, TX; Duke University Medical Center, Durham, NC
| Add |
| 9:15 |
Methylation Analysis of Four Genes in Negative Prostate Needle Biopsies Prior to Diagnosis of Cancer
(704)
M Amin, SH Merchant, AA Martinez, FA Vicini, SV Hunter, NS Goldstein - William Beaumont Hospital, Royal Oak, MI; VA Hospital, Albuquerque, NM; Advanced Diagnostic Lab, Redford, MI
| Add |
| 9:30 |
RECESS, EXHIBITS AND POSTER SESSION III
| |
| 11:00 |
Incidence and Patterns of Prostatic Involvement by Urothelial Carcinoma in Patients with Bladder Cancer Examined by Sagittal Whole-Mount Section
(874)
SS Shen, JY Ro, YW Park, SP Lerner, AG Ayala - The Methodist Hospital and Research Institute, Houston; Hanyang University Hospital, Guri, Korea; Baylor College of Medicine, Houston, TX
| Add |
| 11:15 |
Atypical Small Acinar Proliferation, When Combined with Prostatic Intraepithelial Neoplasia on Biopsy, Has a Higher Rate of Cancer Detection on Subsequent Biopsies Than When Diagnosed Alone
(827)
JL Merrimen, G Jones, CS Leung, LR Kapusta, JR Srigley - McMaster University, Hamilton, Canada; Mount Sinai Hospital, and University of Toronto, Toronto, Canada
| Add |
| 11:30 |
Atypical Cribiform Lesions of the Prostate: Implications for Diagnosis in Prostate Biopsies
(926)
M Zhou, C Magi-Galluzzi, R Shah - Cleveland Clinic, Cleveland, OH; University of Michigan, Ann Arbor, MI
| Add |
| 11:45 |
FAS-N Expression in Prostate Cancer: Can It Be Used To Distinguish Cancer from Benign in Prostate Biopsies?
(920)
J Zhang, G Msangi, S Bryant, E Ryu, T Sebo - Mayo Clinic, Rochester, MN
| Add |
|
|
